Stockholders' Deficit (Summarizes The Stock Warrant Activity) (Details) - Warrants [Member] - USD ($) |
12 Months Ended | |
---|---|---|
Dec. 31, 2019 |
Dec. 31, 2018 |
|
Shares | ||
Outstanding at Beginning of Period | 1,847,447 | 186,550 |
Granted | 2,370,298 | 1,827,564 |
Exercised | (192,521) | |
Forfeitures or expirations | 14,113 | 166,667 |
Outstanding at End of Period | 4,011,111 | 1,847,447 |
Exercisable at End of Period | 4,011,111 | |
Weighted Average Exercise Price | ||
Outstanding at Beginning of Period | $ 2.40 | |
Granted | $ 1.98 | 2.34 |
Exercised | 1.78 | |
Forfeitures or expirations | 1.80 | $ 1.50 |
Outstanding at End of Period | 2.15 | |
Exercisable at End of Period | $ 2.15 | |
Weighted Average Remaining Contractual Term | ||
Outstanding at End of Period | 3 years 7 months 6 days | |
Exercisable at End of Period | 3 years 7 months 6 days | |
Aggregate Intrinsic Value | ||
Outstanding at Beginning of Period | $ 1,873,492 | |
Outstanding at End of Period | ||
Exercisable at End of Period |
X | ||||||||||
- Definition Share based compensation other than option exercisable non vested No definition available.
|
X | ||||||||||
- Definition Share based compensation other than option exercisable weighted average exercise price No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Weighted average fair value as of the grant date of equity-based award plans other than stock (unit) option plans that were not exercised or put into effect as a result of the occurrence of a terminating event. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- Definition Per share or unit weighted-average fair value of nonvested award under share-based payment arrangement. Excludes share and unit options. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition A roll forward is a reconciliation of a concept from the beginning of a period to the end of a period. No definition available.
|
X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Intrinsic value of outstanding award under share-based payment arrangement. Excludes share and unit options. No definition available.
|
X | ||||||||||
- Details
|